- $207.37m
- $208.33m
- $66.58m
Brief: Exagen Inc. Q1 Revenue USD 15.498 Million Vs. IBES Estimate USD 14.5 Million
Exagen Inc expected to post a loss of 20 cents a share - Earnings Preview
Brief: Exagen posts smaller-than-expected fourth-quarter net loss
Exagen Inc reports results for the quarter ended December 31 - Earnings Summary
Exagen Inc expected to post a loss of 26 cents a share - Earnings Preview
Exagen Inc reports results for the quarter ended September 30 - Earnings Summary
Exagen Inc expected to post a loss of 29 cents a share - Earnings Preview
Exagen Inc reports results for the quarter ended in March - Earnings Summary
Exagen Inc expected to post a loss of 36 cents a share - Earnings Preview
Exagen Inc reports results for the quarter ended in December - Earnings Summary
Exagen Inc expected to post a loss of 43 cents a share - Earnings Preview
Brief: Exagen Inc Files For Mixed Shelf Of Upto $150 Million - SEC Filing
Brief: Exagen May, From Time To Time, Continue To Issue, Sell Shares Of Common Stock, Having An Aggregate Offering Price Of Up To $50 Million
Exagen Inc reports results for the quarter ended in June - Earnings Summary
Brief: Exagen Inc. Outlook Q3 Revenue USD 10-10.5 Mln
Exagen Inc expected to post a loss of 49 cents a share - Earnings Preview
Exagen soars on upbeat first-quarter results
Exagen Inc reports results for the quarter ended in March - Earnings Summary
Brief: Exagen Inc. Reports First Quarter 2023 Results